Xanthochromic Compounds in Cerebrospinal Fluid

Kjellin, K.G.

doi:10.1007/978-1-4615-9269-3_33

Cited by 2 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…If bilirubin alone is detected, quantitation is required with a correction to allow for non-haemorrhagic sources, such as influx of protein bound bilirubin across the blood-brain barrier (see below). 20 Measured CSF bilirubin concentration (µmol/litre) = (A453 − A578) × 23, where 578 nm is the wavelength at which oxyhaemoglobin has identical absorbance to its absorbance at 453 nm, and 23 is the extinction coefficient for bilirubin (µmol/litre) at a wavelength of 453 nm.…”

Section: Detection Of Bilirubin Alonementioning

confidence: 99%

ACP Best Practice No 166: CSF spectrophotometry in the diagnosis of subarachnoid haemorrhage

Cruickshank

2001

Journal of Clinical Pathology

View full text Add to dashboard Cite

After subarachnoid haemorrhage (SAH), cerebral angiography is usually performed to establish a site of bleeding, which may then be treated surgically to prevent a potentially catastrophic re-bleed. The investigation of choice in the diagnosis of SAH is computerised tomography (CT). However, because CT can miss some patients with SAH, cerebrospinal fluid (CSF) spectrophotometry should be performed in those patients with negative or equivocal CT scans or those who have presented several days after the suspected bleed. Spectrophotometry should aim to detect the presence of both oxyhaemoglobin and bilirubin because either one or both of these pigments may contribute to xanthochromia following SAH. CSF supernatant is scanned using a double beam spectrophotometer at wavelengths between 350 nm and 650 nm. Oxyhaemoglobin alone produces an absorption peak at 413-415 nm, bilirubin alone produces a broad peak at 450-460 nm, and bilirubin together with oxyhaemoglobin produce a shoulder at 450-460 nm on the downslope of the oxyhaemoglobin peak. To minimise the frequency of false positive and false negative results, a protocol has been developed, which is described.

show abstract

Section: Detection Of Bilirubin Alonementioning

confidence: 99%